Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business

Japan's Fujifilm Holdings Corp will buy a drugmaking business from U.S.-based Biogen Inc for about $890 million (674.8 million pounds) to try to bolster its healthcare business as growth at its legacy photocopy operations stagnates.